Water Technologies International, Inc. Utilizing OriginClear’s Technologies To Pave New Roads zpr.io/nLSnA

TapImmune Announces Pricing of $70 Million Private Placement zpr.io/nJFKH

OriginClear Licenses Technology to Water Technologies International, Inc. (WTII) for Southeastern USA zpr.io/neXqQ

TapImmune Partnership with Big Pharma? If Geography and Finances are Right, says CEO zpr.io/ne82E

TapImmune and Marker Moving Ahead on Merger with Goal of Creating New Immuno-Oncology Platform zpr.io/ne82M

TapImmune Poised To Become A Cell Therapy Leader, WBB Securities Says In Upgrade zpr.io/ne82m

This Jacksonville Company’s Stock is Surging as the Market Sees There’s “No Competitor” zpr.io/6UNa8

No Revenue, but TapImmune Leads Pack zpr.io/6sxmA

Companies Merge to Implement Baylor College of Medicine-Developed Therapies for Cancer zpr.io/6mykB

FISION and Continuity Logic Announce Entry into Merger Agreement, Creating a First of its Kind Cloud Platform for Critical Business Processes, from Digital Asset Management and Agile Marketing, to Business Continuity and Risk Management zpr.io/6mwcy

TapImmune to Participate at Two Upcoming Industry Conferences zpr.io/6yc85

TapImmune To Present at 2018 Janney Healthcare Conference zpr.io/6bskq

FISION Named #1 Software Company in Minnesota by Twin Cities Business Magazine zpr.io/6wFC2

TapImmune’s HER2/neu-Targeted Breast Cancer Vaccine to be Studied in a Large Phase 2 Immunotherapy Combination Study Funded by an $11 Million U.S. Department of Defense Grant zpr.io/6FTgZ

Youngevity’s Hemp FXTM Now Available for Purchase Online zpr.io/6rYxv

Marker to Present at Two Upcoming Cellular Therapy Conferences zpr.io/6ruBM

The Art of the Question zpr.io/65mRr

Marker Therapeutics to Present at Three Upcoming Healthcare Conferences zpr.io/65LUK

Marker Therapeutics, Inc. Appoints Anthony H. Kim as Chief Financial Officer zpr.io/6esMx

The Center for Cell and Gene Therapy at Baylor College of Medicine to Present at the 60th American Society of Hematology Annual Meeting zpr.io/6eNVA